Results

Total Results: 327 records

Showing results for "analyzed".

  1. srdr.ahrq.gov/projects/1520/studies/186810
    January 01, 2019 - )      Population: All Participants Time Point Measure Elective surgery 30 days N Analyzed … )      Population: All Participants Time Point Measure Elective surgery 30 days N Analyzed … )      Population: All Participants Time Point Measure Elective surgery 30 days N Analyzed … )      Population: All Participants Time Point Measure Elective surgery 30 days N Analyzed
  2. srdr.ahrq.gov/projects/1565/studies/189213
    January 01, 2013 - Population: All Participants Time Point Measure CPAP Baseline N/A N Analyzed … SD 24.9 SE 17.8 (11.4) months N Analyzed … Population: All Participants Time Point Measure CPAP 17.8 (11.4) months N Analyzed
  3. srdr.ahrq.gov/projects/1520/studies/186741
    January 01, 2010 - Elective surgery Enter a numeric value or title (required) years N Analyzed 3468 … Elective surgery Enter a numeric value or title (required) years N Analyzed 3468 … Elective surgery Enter a numeric value or title (required) years N Analyzed 3468 … Elective surgery 30 days N Analyzed 3468 3502 P-Value 0.0004 … Elective surgery N/A years N Analyzed 3468 3502 P-Value 0.0039
  4. srdr.ahrq.gov/projects/1565/studies/189572
    January 01, 2013 - No CPAP Baseline N/A N Analyzed 56 35 … 41.2 Note 36.5+/-3.7 months N Analyzed … No CPAP Baseline N/A N Analyzed 56 35 … 65.0 Note 36.5+/-3.7 months N Analyzed
  5. srdr.ahrq.gov/projects/1565/studies/189189
    January 01, 2015 - No CPAP Baseline N/A N Analyzed 33 93 … 0.85 0.52 SE 10 years N Analyzed … No CPAP Baseline N/A N Analyzed 33 93 … 0.25 Note SE 10 years N Analyzed
  6. srdr.ahrq.gov/projects/1565/studies/198894
    January 01, 2004 - No CPAP Before N/A N Analyzed 82 89 … 1.04 0.96 SE >6 months N Analyzed … No CPAP Before N/A N Analyzed 82 89 … 0.81 0.74 SE >6 months N Analyzed
  7. srdr.ahrq.gov/projects/1520/studies/186750
    January 01, 2014 - Pharm: 5-ASA (4.8 g/d) 104 weeks N Analyzed 147 143 143 … Measure Placebo Pharm: 5-ASA (1.2 g/d) Pharm: 5-ASA (2.4 g/d) Pharm: 5-ASA (4.8 g/d) 104 weeks N Analyzed … Measure Placebo Pharm: 5-ASA (1.2 g/d) Pharm: 5-ASA (2.4 g/d) Pharm: 5-ASA (4.8 g/d) 104 weeks N Analyzed … Measure Placebo Pharm: 5-ASA (1.2 g/d) Pharm: 5-ASA (2.4 g/d) Pharm: 5-ASA (4.8 g/d) 104 weeks N Analyzed … Measure Placebo Pharm: 5-ASA (1.2 g/d) Pharm: 5-ASA (2.4 g/d) Pharm: 5-ASA (4.8 g/d) 104 weeks N Analyzed
  8. srdr.ahrq.gov/projects/1565/studies/198064
    January 01, 2021 - CPAP 2.5 years N Analyzed 260 318 … CPAP 2.5 years N Analyzed 260 318 … No CPAP 2.5 years N Analyzed 260 318
  9. srdr.ahrq.gov/projects/1565/studies/188512
    January 01, 2019 - Point Measure CPAP No CPAP Enter a numeric value or title (required) years N Analyzed … Point Measure CPAP No CPAP Enter a numeric value or title (required) years N Analyzed … No CPAP Enter a numeric value or title (required) years N Analyzed 1030
  10. srdr.ahrq.gov/projects/1520/studies/193255
    January 01, 2019 - Participants Time Point Measure Colonoscopy Enter a numeric value or title (required) years N Analyzed … Participants Time Point Measure Colonoscopy Enter a numeric value or title (required) years N Analyzed
  11. srdr.ahrq.gov/projects/1520/studies/192909
    January 01, 2019 - Participants Time Point Measure Colonoscopy Enter a numeric value or title (required) years N Analyzed … Participants Time Point Measure Colonoscopy Enter a numeric value or title (required) years N Analyzed
  12. srdr.ahrq.gov/projects/1520/studies/186844
    January 01, 2017 - Pharm: rifaximin 15 months N Analyzed 72 52 Adj. … Population: All Participants Time Point Measure Pharm: rifaximin Pharm: 5-ASA 15 months N Analyzed … Population: All Participants Time Point Measure Pharm: rifaximin Pharm: 5-ASA 15 months N Analyzed … Population: All Participants Time Point Measure Pharm: rifaximin Pharm: 5-ASA 24 months N Analyzed
  13. srdr.ahrq.gov/projects/1520/studies/197240
    January 01, 2020 - )      Population: All Participants Time Point Measure Elective surgery 1 years N Analyzed … 6811 Counts 129 Percentage 1.9 3 years N Analyzed 6811 … Counts 272 Percentage 4.0 5 years N Analyzed 6811 Counts
  14. srdr.ahrq.gov/projects/1520/studies/186228
    January 01, 2012 - Setting: Outpatient management 9 +/- 18 (hospital); 7 +/- 9 months (outpatient) months N Analyzed … Setting: Outpatient management 9 +/- 18 (hospital); 7 +/- 9 months (outpatient) months N Analyzed … Setting: Outpatient management 9 +/- 18 (hospital); 7 +/- 9 months (outpatient) months N Analyzed … Setting: Outpatient management 9 +/- 18 (hospital); 7 +/- 9 months (outpatient) months N Analyzed
  15. srdr.ahrq.gov/projects/1565/studies/188743
    January 01, 2016 - No CPAP 53 (IQR 41-77) months N Analyzed Adj. … No CPAP 53 (IQR 41-77) months N Analyzed Adj. … No CPAP 50 (IQR 23-77) months N Analyzed Adj. 95% CI low
  16. srdr.ahrq.gov/projects/1520/studies/186845
    January 01, 2014 - Time Point Measure Pharm: 5-ASA (4.8 g/d) Enter a numeric value or title (required) years N Analyzed … Time Point Measure Pharm: 5-ASA (4.8 g/d) Enter a numeric value or title (required) years N Analyzed … Time Point Measure Pharm: 5-ASA (4.8 g/d) Enter a numeric value or title (required) years N Analyzed
  17. srdr.ahrq.gov/projects/1520/studies/186848
    January 01, 2018 - Time Point Measure Colonoscopy No Colonoscopy Enter a numeric value or title (required) years N Analyzed … Time Point Measure Colonoscopy No Colonoscopy Enter a numeric value or title (required) years N Analyzed
  18. srdr.ahrq.gov/projects/1520/studies/186799
    January 01, 2019 - Antibiotics: Cephalosporin + Metronidazole Enter a numeric value or title (required) years N Analyzed … Antibiotics: Cephalosporin + Metronidazole Enter a numeric value or title (required) years N Analyzed … Antibiotics: Cephalosporin + Metronidazole Enter a numeric value or title (required) years N Analyzed
  19. srdr.ahrq.gov/projects/1520/studies/186762
    January 01, 2014 - Pharm: 5-ASA 104 weeks N Analyzed 142 148 147 149 … Participants Time Point Measure Placebo Pharm: 5-ASA Pharm: 5-ASA Pharm: 5-ASA 104 weeks N Analyzed … Participants Time Point Measure Placebo Pharm: 5-ASA Pharm: 5-ASA Pharm: 5-ASA 104 weeks N Analyzed … Participants Time Point Measure Placebo Pharm: 5-ASA Pharm: 5-ASA Pharm: 5-ASA 104 weeks N Analyzed
  20. srdr.ahrq.gov/projects/1542/studies/189228
    January 01, 2015 - Time Point Measure Single-pulse transcranial magnetic stimulation Unclear N/A N Analyzed … Time Point Measure Single-pulse transcranial magnetic stimulation Unclear N/A N Analyzed … Time Point Measure Single-pulse transcranial magnetic stimulation Unclear N/A N Analyzed

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: